We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 04, 2022

Impact of Previous Disease-Modifying Treatment on Safety and Efficacy in Patients With MS Treated With AHSCT

Journal of Neurology, Neurosurgery, and Psychiatry


Additional Info

Journal of Neurology, Neurosurgery, and Psychiatry
Impact of previous disease-modifying treatment on safety and efficacy in patients with MS treated with AHSCT
J. Neurol. Neurosurg. Psychiatr. 2022 Aug 01;93(8)844-848, SAS Kvistad, J Burman, AK Lehmann, A Tolf, C Zjukovskaja, GK Melve, L Bø, Ø Torkildsen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading